2021 CMSC Annual Meeting

THE EYES HAVE IT

CREDITS: CME, CNE, PA
Expiration: 30-Apr-22
Level of Information: Intermediate

Assessment of vision is a challenging but important component of the evaluation of patients with multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendroctye glycoprotein antibody-associated disorder (MOGAD).
This session will highlight the assessment of optic neuritis, distinguishing between MS, NMOSD and MOGAD, will explore the role of optical coherence tomography (OCT) in the evaluation of demyelinating disorders, and will revisit the question of whether to treat patients with a clinically isolated syndrome (CIS).

Presentations and Speakers

Introduction Robert K. Shin, MD
Optical Coherence Tomography (OCT) in MS Shiv Saidha, MBBCh, MRCPI
Optic Neuritis: MS, NMOSD or MOGAD? John J. Chen, MD, PhD
Revisiting the Clinically Isolated Syndrome Robert K. Shin, MD
Discussion and Q&A Panel

You can only claim credits for this On-demand Video if you have not done so for the Live Event.